Substance Use Tools & Resources    

This paper offers principle and recommendations for remediating the impacts of the rising rates of drugs adulterated or laced with fentanyl.

Based on 2020 and earlier NSDUH data, this report contains findings on a wide variety of key substance use and mental health indicators in the United States.

This research report from NIDA discusses effective prevention and treatment strategies for opioid misuse and use disorder, and overcoming the misunderstandings and other barriers that prevent wider adoption of these treatments.

This NIDA web page includes facts and figures on prescription opioids.

This two-day public workshop convened regulators, academic researchers, clinicians, patient advocates, and other stakeholders to share information underlying this action and gather input related to the safe use of benzodiazepines.

This toolkit, informed by interviews with key leaders across several states, examines state policy actions at each of the intercept levels defined in the Sequential Intercept Model framework, and explores opportunities for states to successfully integrate treatment and prevention services across the behavioral health and criminal justice continuum.

A Protocol using empirically-supported behavioral treatments for people with psychoactive stimulant use disorders. There are manuals for healthcare professionals who provide treatment services for individuals with psychoactive substance use disorder (PSUD) and for patients who are entering PSUD treatment.

This Clinical Practice Guideline (CPG) provides an evidence-based framework for evaluating, treating, and managing the individual needs of patients with substance use disorders (SUD), including alcohol use disorder, in the VA and DoD. It is intended for use by all VA and DoD healthcare providers.

These reports and detailed tables present estimates from the 2019 National Survey on Drug Use and Health (NSDUH), specifically pertaining to substance use among women.

This guideline develops a framework to evaluate existing clinical practice guidelines for prescribing opioids for acute pain indications and recommends indications for which new evidence-based guidelines should be developed.